بدائل البحث:
larger decrease » marked decrease (توسيع البحث)
mapk decrease » marked decrease (توسيع البحث), small decrease (توسيع البحث), mean decrease (توسيع البحث)
step decrease » sizes decrease (توسيع البحث), teer decrease (توسيع البحث), we decrease (توسيع البحث)
_ decrease » _ decreased (توسيع البحث), _ decreasing (توسيع البحث)
_ larger » _ large (توسيع البحث), _ largest (توسيع البحث), a large (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
mapk decrease » marked decrease (توسيع البحث), small decrease (توسيع البحث), mean decrease (توسيع البحث)
step decrease » sizes decrease (توسيع البحث), teer decrease (توسيع البحث), we decrease (توسيع البحث)
_ decrease » _ decreased (توسيع البحث), _ decreasing (توسيع البحث)
_ larger » _ large (توسيع البحث), _ largest (توسيع البحث), a large (توسيع البحث)
-
1
-
2
-
3
Diagram of Outdoor Terrains; Participants performed two loops (clockwise and counterclockwise).
منشور في 2025الموضوعات: -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Inhibition of NEAT1 decreased the miR-204-5p expression and increased Six1 expression.
منشور في 2024"…<p>(A) NEAT1 expression following siRNA transfection in BEAS-2B cells; (B-D) The expression of NEAT1, miR-204-5p, and Six1 after decreasing NEAT1 expression. * p <0.05, *** p < 0.001, and **** p <0.0001.…"
-
14
Biases in larger populations.
منشور في 2025"…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. Bias decreases with increasing neurons in the population. …"
-
15
-
16
Table 2_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.docx
منشور في 2025"…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…"
-
17
Image 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.pdf
منشور في 2025"…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…"
-
18
Table 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.docx
منشور في 2025"…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…"
-
19
Data Sheet 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.zip
منشور في 2025"…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…"
-
20